The Path to a 4H Diagnosis: MRI and Genetics
At a Glance
A 4H leukodystrophy diagnosis uses MRI clues—such as diffuse hypomyelination, cerebellar atrophy, myelin islets, or the closed-eye sign—plus genetic testing that finds disease-causing variants in both copies of an associated gene.
The journey to a diagnosis of 4H leukodystrophy often begins with a brain MRI, but the final confirmation usually comes from genetic testing. Because 4H is so rare, doctors look for suggestive clues on brain scans and in the DNA to distinguish it from other similar conditions [1][2].
The MRI Clues
A brain MRI (Magnetic Resonance Imaging) is the most important tool for identifying hypomyelination (the lack of brain “insulation”). While many leukodystrophies show hypomyelination, certain findings can raise suspicion for 4H, though they are not a required “signature” and their absence does not exclude POLR3-related disease [3][4].
- Diffuse Hypomyelination: This is the primary finding. The white matter of the brain, which should look dark on certain types of MRI images (T2-weighted), instead looks bright because the myelin is missing [3][5].
- The “Closed-Eye” Sign: In the lower part of the brain (the brainstem), two small structures called the medial lemnisci may appear as dark, eye-shaped spots against a bright background, looking like a pair of closed eyes [5].
- Myelin Islets: Doctors may see small, scattered “islets” of normal myelin. These look like tiny dark spots (on T2 images) or bright spots (on T1 images) within the otherwise white, unmyelinated areas [5].
- Cerebellar Atrophy: The cerebellum (the part of the brain that controls balance) may appear smaller than normal. This often explains why balance issues are one of the first symptoms [3][6].
- Thin Corpus Callosum: The bridge of tissue connecting the two halves of the brain is often unusually thin [3].
These findings require interpretation by an experienced neuroradiologist in the clinical and genetic context.
Genetic Confirmation
To confirm 4H, genetic testing must find biallelic variants—meaning two disease-causing alleles, one inherited from each parent—in one of the specific genes associated with the condition. These can be compound heterozygous (two different variants) or homozygous (two copies of the same variant) [7][8].
The primary established genes involved are:
- POLR3A and POLR3B: The most common causes of 4H [9][10].
- POLR1C and POLR3K: These are less common but cause very similar symptoms [11].
- POLR3D: Emerging functional evidence has also identified this as a very rare cause of POLR3-related leukodystrophy [4][12].
Navigating Genetic Results
If a person has all the physical and MRI signs of 4H, but testing only finds one variant, it does not mean the diagnosis is wrong. Your doctor may recommend reviewing test coverage or performing deletion/duplication analysis (to find missing chunks of DNA) before assuming broader whole-genome sequencing is automatically indicated [13][14].
A Variant of Uncertain Significance (VUS) cannot establish the diagnosis or guide disease-specific treatment on its own. Discussing an uncertain result with a genetic counselor can help determine if family testing or future re-evaluation is needed.
Genetic Look-Alikes (Differential Diagnosis)
Several other conditions can look like 4H on an MRI, and genetic testing is the only way to tell them apart [1].
- Pelizaeus-Merzbacher Disease (PMD): Usually affects boys and is caused by the PLP1 gene. It often features early eye-shaking (nystagmus) [15].
- H-ABC (TUBB4A-related): This condition causes hypomyelination but also features the disappearance of a specific brain structure called the putamen [16].
- FAM126A-related Leukodystrophy: This looks very similar to 4H but is almost always accompanied by congenital cataracts (cloudy eyes at birth) [17].
Diagnosis Completeness Checklist
A diagnosis evaluation should provide you with several specific pieces of information. If these are missing, you may want to ask your doctor for a more detailed review.
| Document | What to Look For |
|---|---|
| MRI Report | Mentions of hypomyelination, cerebellar atrophy, and any “islets” or specific signs like the “closed-eye” appearance [5][3]. |
| Genetic Report | The specific gene name (e.g., POLR3A) and the “c.” and “p.” numbers for the variants [18][19]. |
| Zygosity | Confirmation of biallelic status, whether homozygous or compound heterozygous. Parental testing can establish whether different variants are in trans (on opposite copies) [18]. |
| Classification | Variants should be labeled as Pathogenic or Likely Pathogenic [19]. |
| Follow-up | If only one variant was found, evidence that deletion/duplication or other clinical reviews were considered [13][14]. |
Common questions in this guide
What can a brain MRI show in 4H leukodystrophy?
How does genetic testing confirm 4H leukodystrophy?
What does it mean if testing finds only one POLR3 variant?
Can a variant of uncertain significance diagnose 4H leukodystrophy?
What conditions can look like 4H leukodystrophy on an MRI?
Get notified when new evidence is published on 4H leukodystrophy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (19)
- 1
Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.
Ji H, Li D, Wu Y, et al.
PloS one 2018; (13(2)):e0188869 doi:10.1371/journal.pone.0188869.
PMID: 29451896 - 2
Genetic heterogeneity in 26 infants with a hypomyelinating leukodystrophy.
Arai-Ichinoi N, Uematsu M, Sato R, et al.
Human genetics 2016; (135(1)):89-98 doi:10.1007/s00439-015-1617-7.
PMID: 26597493 - 3
Diffuse hypomyelination is not obligate for POLR3-related disorders.
La Piana R, Cayami FK, Tran LT, et al.
Neurology 2016; (86(17)):1622-6 doi:10.1212/WNL.0000000000002612.
PMID: 27029625 - 4
Biallelic pathogenic variants in POLR3D alter tRNA transcription and cause a hypomyelinating leukodystrophy: A case report.
Macintosh J, Perrier S, Pinard M, et al.
Frontiers in neurology 2023; (14()):1254140 doi:10.3389/fneur.2023.1254140.
PMID: 37915380 - 5
4H Leukodystrophy: Lessons from 3T Imaging.
Cayami FK, Bugiani M, Pouwels PJW, et al.
Neuropediatrics 2018; (49(2)):112-117 doi:10.1055/s-0037-1608780.
PMID: 29179231 - 6
Tremor Ataxia With Central Hypomyelation Phenotype Related to a Recurrent POLR3A Mutation in Six Unrelated Tunisian Families.
Kraoua I, Jamoussi M, Drissi C, et al.
Molecular genetics & genomic medicine 2024; (12(10)):e70007 doi:10.1002/mgg3.70007.
PMID: 39436788 - 7
POLR3-related leukodystrophy: How do mutations affecting RNA polymerase III subunits cause hypomyelination?
Coulombe B, Derksen A, La Piana R, et al.
Faculty reviews 2021; (10()):12 doi:10.12703/r/10-12.
PMID: 33659930 - 8
A novel homozygous mutation in POLR3A gene causing 4H syndrome: a case report.
Tewari VV, Mehta R, Sreedhar CM, et al.
BMC pediatrics 2018; (18(1)):126 doi:10.1186/s12887-018-1108-9.
PMID: 29618326 - 9
Inherited white matter disorders: Hypomyelination (myelin disorders).
Perrier S, Gauquelin L, Bernard G
Handbook of clinical neurology 2024; (204()):197-223 doi:10.1016/B978-0-323-99209-1.00014-4.
PMID: 39322379 - 10
The First Case of 4H Syndrome with Type 1 Diabetes Mellitus
Büyükyılmaz G, Erozan Çavdarlı B, Toksoy Adıgüzel K, et al.
Journal of clinical research in pediatric endocrinology 2025; (17(1)):103-108 doi:10.4274/jcrpe.galenos.2023.2023-1-15.
PMID: 36974356 - 11
Endocrine and Growth Abnormalities in 4H Leukodystrophy Caused by Variants in POLR3A, POLR3B, and POLR1C.
Pelletier F, Perrier S, Cayami FK, et al.
The Journal of clinical endocrinology and metabolism 2021; (106(2)):e660-e674 doi:10.1210/clinem/dgaa700.
PMID: 33005949 - 12
Novel Pathogenic Variants in POLR3K Cause POLR3-Related Leukodystrophy.
Perrier S, Macintosh J, Misiaszek AD, et al.
Human mutation 2024; (2024()):8807171 doi:10.1155/2024/8807171.
PMID: 40225923 - 13
Large exonic deletions in POLR3B gene cause POLR3-related leukodystrophy.
Gutierrez M, Thiffault I, Guerrero K, et al.
Orphanet journal of rare diseases 2015; (10()):69 doi:10.1186/s13023-015-0279-9.
PMID: 26045207 - 14
Identification of a deep intronic POLR3A variant causing inclusion of a pseudoexon derived from an Alu element in Pol III-related leukodystrophy.
Hiraide T, Nakashima M, Ikeda T, et al.
Journal of human genetics 2020; (65(10)):921-925 doi:10.1038/s10038-020-0786-y.
PMID: 32483275 - 15
[Clinical features and diagnosis of Pelizaeus-Merzbacher disease: five case reports].
Espinosa E, Mera-Solarte PR, Cote-Orozco JE
Revista de neurologia 2016; (62(9)):411-4.
PMID: 27113066 - 16
[Hypomyelinating leukodystrophy type 6. Clinical and neuroimaging key features in the detection of a new case].
Otero-Dominguez E, Gomez-Lado C, Fuentes-Pita P, et al.
Revista de neurologia 2018; (67(9)):339-342.
PMID: 30350845 - 17
Hypomyelination and Congenital Cataract: Three Siblings Presentation.
Karalok ZS, Gurkasb E, Aydinc K, Ceylaner S
Journal of pediatric neurosciences 2020; (15(3)):270-273 doi:10.4103/jpn.JPN_161_18.
PMID: 33531944 - 18
Novel mutations of the POLR3A gene caused POLR3-related leukodystrophy in a Chinese family: a case report.
Wu S, Bai Z, Dong X, et al.
BMC pediatrics 2019; (19(1)):289 doi:10.1186/s12887-019-1656-7.
PMID: 31438894 - 19
Identification of a Novel Missense Mutation of POLR3A Gene in a Cohort of Sicilian Patients with Leukodystrophy.
Musumeci A, Calì F, Scuderi C, et al.
Biomedicines 2022; (10(9)) doi:10.3390/biomedicines10092276.
PMID: 36140376
This page provides general information about MRI and genetic testing for 4H leukodystrophy and does not constitute medical advice. A neurologist, neuroradiologist, or genetic counselor should interpret your specific reports.